Welcome to our dedicated page for Ambiq Micro news (Ticker: AMBQ), a resource for investors and traders seeking the latest updates and insights on Ambiq Micro stock.
Ambiq Micro, Inc. develops ultra-low-power semiconductor solutions for edge AI as a fabless chip company. Its recurring news centers on SPOT® subthreshold power technology, Apollo and Atomiq system-on-chip products, neuralSPOT software, and AI development tools such as soundKIT and compressionKIT for on-device sensing, audio, speech, graphics, security, storage, wireless connectivity, and sensor-data compression.
Company updates also cover financial results, customer demand, margin trends, geographic revenue mix, common stock offerings, and shareholder voting or capital-structure matters tied to its NYSE-listed common stock.
Ambiq (NYSE: AMBQ) reported first quarter 2026 net sales of $25.1 million, up 59.3% year-over-year and 20.8% sequentially, driven by expanding edge AI demand. GAAP gross margin was 43.5%; non-GAAP gross margin was 46.2%.
GAAP net loss was $10.2 million, while non-GAAP net loss was $5.0 million/b. For second quarter 2026, Ambiq guides net sales of , non-GAAP gross margin of 45–46%, and non-GAAP net loss per share of ($0.29)–($0.23).
Ambiq (NASDAQ:AMBQ) announced compressionKIT, a beta AI-based codec that reduces memory, storage and transmission costs for continuous sensor data in always-on edge devices.
Key claims include up to 20x data compression, up to 16x lower on-device memory usage, configurable 2x–20x targets, multiple inference deployment options, and hybrid DSP+ML or neural-compression modes. compressionKIT is in beta with rolling improvements planned.
Ambiq Micro (NYSE: AMBQ) will report first quarter 2026 financial results on Tuesday, May 12, 2026 before market open. A conference call is scheduled for 7:30 a.m. Central Time (8:30 a.m. Eastern Time) with a live webcast and replay available on the company’s Investor Relations website.
Ambiq (NYSE: AMBQ) reported full year 2025 net sales of $72.5 million and fourth quarter net sales of $20.7 million, the highest quarter in 2025. GAAP gross margin was 42.7% (Q4) and non-GAAP gross margin was 45.5% (Q4). Full year gross profit rose to $32.1 million, the highest in company history. Ambiq completed an upsized IPO and a follow-on, generating net proceeds of $102.7 million and $76.8 million. Q1 2026 guidance calls for net sales of $21.0–$22.0 million and non-GAAP gross margin of 44–45%.
Ambiq (AMBQ) unveiled technical details of its Atomiq SoC built on a new 12nm SPOT platform using TSMC N12e, introducing an Ultra‑Low‑Power mode that operates down to 300mV. Atomiq110 samples are progressing toward production scheduled for 2027, with silicon validation completed in Ambiq labs.
The SoC targets edge AI with an Arm Ethos‑U85 NPU capable of tens of billions of MACs per second even in ULP mode, and includes a multi‑channel SIMO buck converter and custom foundation IP for reliable ultra‑low‑voltage operation.
Ambiq Micro (NYSE: AMBQ) will report fourth quarter and full year 2025 financial results on Thursday, March 5, 2026 after market close.
The company will host a conference call on March 6, 2026 at 7:30 a.m. Central Time (8:30 a.m. ET) with a live webcast and telephone replay available through June 3, 2026; webcast replays remain on the investor site for ~90 days.
Ambiq (NASDAQ:AMBQ) launched soundKIT, an open-source audio AI Development Kit to enable always-on, on-device speech and audio intelligence for ultra-low-power edge devices.
soundKIT offers end-to-end tools—data prep, training, evaluation, export, and real-time demos—and integrates with Ambiq SoCs. It is available now on GitHub with documentation online.
Ambiq (NYSE: AMBQ) priced an upsized underwritten public offering of 2,679,600 common shares at $31.00 per share. Ambiq is offering 2,636,651 shares and certain stockholders are offering 42,949 shares. Gross proceeds to Ambiq are expected to be approximately $81.7 million before underwriting discounts, commissions, and expenses. The company granted underwriters a 30-day option to purchase up to an additional 401,940 shares at the public offering price less underwriting discounts and commissions. The offering is expected to close on January 26, 2026, subject to customary closing conditions.
Ambiq (NYSE: AMBQ) announced on January 21, 2026 the commencement of an underwritten public offering of 2,200,000 shares of common stock, including 2,157,051 shares offered by Ambiq and 42,949 shares offered by certain stockholders.
The company said it expects to grant underwriters a 30‑day option to purchase up to an additional 330,000 shares at the public offering price, less underwriting discounts and commissions. The offering is subject to market conditions and the registration statement on Form S‑1 filed with the SEC has not yet become effective.
BofA Securities and UBS Investment Bank are joint lead book‑running managers; Needham and Stifel are joint book‑running managers. No assurance exists as to whether or when the offering will be completed.
Ambiq (NYSE: AMBQ) announced Atomiq, a new ultra-low-power SoC with an integrated NPU built on Ambiq’s Subthreshold Power Optimized Technology (SPOT) to enable always-on edge AI.
Key claims include a SPOT-optimized NPU, >b>200 GOPS on-device AI performance via Arm Ethos-U85, SPOT-enabled dynamic voltage and frequency scaling for lower-power sustained AI, and a software stack (Helia AI, ADK, neuralSPOT SDK) for smaller memory footprints and faster time-to-market. Ambiq cited ecosystem deployments (over 400,000 Ronds sensors, partnerships with Bravechip) and noted additional technical details on a 12nm SPOT roadmap to be shared beginning March 2026.